Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Department of Genome Informatics, Osaka University Graduate School of Medicine, Osaka, Japan.
Heart Vessels. 2021 Oct;36(10):1484-1495. doi: 10.1007/s00380-021-01836-9. Epub 2021 Mar 20.
The Japanese high-bleeding-risk criteria (Japanese-HBR), modified criteria of the Academic Research Consortium (ARC) HBR, has been recently proposed. We aimed to investigate the prevalence of the ARC-HBR and the Japanese-HBR, and to assess their prognostic significance in patients with acute myocardial infarction (AMI).
We applied the ARC-HBR and the Japanese-HBR criteria to the OACIS prospective multicenter acute myocardial infarction registry (12,093 patients, 66 ± 12 years, 9,096 males). The primary endpoint was fatal bleeding (BARC-5). Median follow-up duration was 4.84 [inter-quartile range 1.35, 5.01] years. Prevalence of the ARC-HBR was 43.8%, while that of the Japanese-HBR was 61.8%. Cumulative incidence of fatal bleeding was higher in the ARC-HBR group than in the no ARC-HBR group at 1 year (1.3 vs. 0.6%) and at 5 years (2.0 vs. 0.7%). The Kaplan-Meier curves stratified by the Japanese-HBR criteria more prominently diverged (1.3 vs. 0.2% at 1 year; and 1.9 vs. 0.3% at 5 years). The Japanese-HBR criteria showed superior discriminative performance over the ARC-HBR criteria (C-statistics: 0.677 vs. 0.598, P < 0.001).
In the real-world Japanese AMI registry, nearly half of the patients fulfilled the criteria of ARC-HBR, and two-thirds met the Japanese-HBR. Our findings support the validity of both ARC- and Japanese-HBR criteria in AMI patients but encourage the future application of the Japanese-HBR criteria to the Japanese AMI cohort.
UMIN000004575.
日本高出血风险标准(Japanese-HBR)是最近提出的,是学术研究联盟(ARC)高出血风险标准的改良标准。我们旨在研究急性心肌梗死(AMI)患者中 ARC-HBR 和 Japanese-HBR 的流行情况,并评估其预后意义。
我们将 ARC-HBR 和 Japanese-HBR 标准应用于 OACIS 前瞻性多中心急性心肌梗死注册研究(12093 例患者,66±12 岁,9096 例男性)。主要终点是致死性出血(BARC-5)。中位随访时间为 4.84[四分位间距 1.35,5.01]年。ARC-HBR 的患病率为 43.8%,而 Japanese-HBR 的患病率为 61.8%。在 1 年(1.3%比 0.6%)和 5 年(2.0%比 0.7%)时,ARC-HBR 组的致死性出血累积发生率高于无 ARC-HBR 组。根据 Japanese-HBR 标准分层的 Kaplan-Meier 曲线明显分开(1 年时为 1.3%比 0.2%;5 年时为 1.9%比 0.3%)。Japanese-HBR 标准比 ARC-HBR 标准具有更好的判别性能(C 统计量:0.677 比 0.598,P<0.001)。
在真实世界的日本 AMI 注册研究中,近一半的患者符合 ARC-HBR 标准,三分之二的患者符合 Japanese-HBR 标准。我们的研究结果支持 ARC-HBR 和 Japanese-HBR 标准在 AMI 患者中的有效性,但鼓励未来在日本 AMI 队列中应用 Japanese-HBR 标准。
UMIN000004575。